期刊文献+

全血灌流免疫吸附治疗被动转移型实验性自身免疫性重症肌无力的研究 被引量:1

Treatment of passively transferred experimental autoimmune myasthenia gravis by extracorporeal whole blood immunoadsorption
下载PDF
导出
摘要 目的观察全血灌流免疫吸附治疗实验性自身免疫性重症肌无力(EAMG)的疗效。方法用重症肌无力患者血清中的免疫球蛋白(IgG)建立急性EAMG模型,并进行全血灌流免疫吸附治疗,观察其疗效。结果以球形纤维素为载体色氨酸为配基的吸附剂治疗2h,能清除49.85%±2.55%的致病抗体,肌无力症状显著改善;重复神经电刺激实验CMAP衰减率从21.875±3.226(3Hz)、22.250±2.815(5Hz)和24.375±1.685(10Hz)恢复到17.875±1.642(P<0.05)、18.750±1.388(P<0.05)和23.250±1.388;单纤维肌电图示MCD值也从23.125±2.997(3Hz)、26.375±4.172(5Hz)和30.375±4.470(10Hz)显著性地缩短至19.250±1.488(P<0.05)、21.750±2.375(P<0.05)和26.125±2.031(P<0.05)MEPP波幅(μV)也从30.54±3.74显著增加至40.43±3.45(P<0.01),频率(次/s)从17.18±2.87显著增加至18.74±2.75(P<0.01);单位面积的神经肌肉接头数从9.825±3.401增加至10.900±2.879(P<0.05)。结论全血灌流免疫吸附治疗能有效清除被动转移型重症肌无力动物体内致病抗体,并相应改善临床症状,提高神经肌肉电传导功能,增加神经肌肉接头处nAChR数量,为临床重症肌无力的血液净化治疗提供了新措施。 Objective To investigate the effects of extracorporeal whole blood immunoadsorption in the treatment of passively transferred experimental autoimmune myasthenia gravis. Methods EAMG rabbits were induced by passively transferred the anti-acetylcholine receptor antibody of myasthenia gravis patients and treated with extracorporeal whole blood adsorption. The improvement of clinical manifestation was evaluated through clinical score,antibody titers,neuromuscular transmission function and neuromuscular junction quantity. Results The pathogenic antibodies were removed by 49. 85%±2. 55% at 2h after treatment. The clinical manifestation improved 3 days after the immunoadsorption. Repetitive nerve stimulation test showed that the percentage of decrement of CMAP dropped from 21. 875±3. 226(3Hz),22. 250±2. 815(5Hz) and 24. 375±1. 685(10Hz) to 17. 875±1. 642 (P 〈 0.05 ), 18. 750 ± 1. 388 (P 〈 0.05) and 23. 250 ± 1. 388, respectively. Single fiber electromyography showed that MCD(μs) decreased significantly from 23. 125 ± 2. 997 (3Hz), 26. 375 ± 4. 172 (5Hz) and 30. 375 ± 4.470(10Hz) to 19.250±1.488 (P〈0.05),21.750±2.375 (P〈0.05) and 26.125±2.031(P〈0.05). The amplitude (μV) of miniature endplate potential(MEPP) increased significantly from 30.54±3.74 to 40.43±3.45 (P〈0. 01). The frequency of MEPP also increased significantly from 17.18±2.87 to 18.74±2.75(P〈0. 01). The quantity of neuromuscular junction per unit area (25mm^2) increased from 9. 825±3. 401 to 10. 900±2. 879(P〈 0.05). Conclusion Extracorporeal whole blood immunoadsorption is very effective in treating the passive experimental autoimmune myasthenia gravis by improving clinical manifestation ,antibody titers ,neuromuscular transmission function and neuromuscular junction quantity.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2007年第5期582-585,共4页 Journal of Apoplexy and Nervous Diseases
基金 天津市社会发展科技计划基金资助项目(033111411)
关键词 重症肌无力 全血灌流免疫吸附治疗 ACHRAB 神经肌肉传递 神经肌肉接头 Myasthenia gravis Extracorporeal whole blood immunoadsorption Neuromuscular transmission function Antibody Neuromuscular junctions
  • 相关文献

参考文献9

  • 1Thanvi BR,Lo TC. Update on myasthenia gravis[J]. Postgrad Med J ,2004,80(950) : 690-700.
  • 2Ptak J. Changes of selected hematologic parameters during long-term immunoadsorption therapy[J]. Transfus Apher Sci, 2005, 33(3) :299-304.
  • 3Ptak J,Loehman J. Immunoadsorption therapy and complement activation[J]. Transfus Apher Sci, 2005,32(3) : 263-267.
  • 4杨丽,程焱.全血灌流吸附治疗重症肌无力的实验研究[J].中华急诊医学杂志,2004,13(10):670-672. 被引量:7
  • 5Yang L,Cheng Y,Yan WR,et al. Extraeorporeal whole blood immunoadsorption of autoimmune myasthenia gravis by cellulose tryptophan adsorbent[J]. Artif Cells Blood Substit Immobil Biotechnol, 2004,32(4):519-528.
  • 6Shibuya N, Sato T, Osame M, et al. Immunoadsorption therapy for myasthenia gravis[J]. J Neuro Neurosur Psyehia, 1994,57: 578-581.
  • 7Grob D,Simpson D,Mitsumoto H,et al. Treatment of myasthenia gravis by immunoadsorption of plasma [J ]. Neurology, 1995,45:338-344.
  • 8Nakaji S,Hayashi N. Adsorption column for myasthenia gravis treatment: Medisorba MG-50[J]. Therap Apher Dial, 2003, 7 (1):78-84.
  • 9Haupt WF,Rosenow F,van der Ven C,et al. Immunoadsorption in Guillain-Barre syndrome and myasthenia gravis[J]. Ther Apher, 2000,4 (3):195-197.

二级参考文献7

  • 1Splendiani G, Cipriani S, Passalacqua S, et al. Plasma perfusion on triptophan columns can improve the clinical outcome of patients affected with myasthenia gravis. Artif Ceils Blood Substit Immobil Biotechnol,2003,31:69-79.
  • 2Marinelli WA, Leatherman JW. Neuromuscular disorders in the intensive care unit. Crit Care Clin, 2002,18: 915-929.
  • 3Batocchi AP, Evoli A, Di Schino C, et al. Therapeutic apheresis in myasthenia gravis.Ther Apher,2000,4:275-279.
  • 4Yang KS, Kenpe K, Yamaji K, et al. Plasma adsorption in critical care.Ther Apher, 2002, 6:184-188.
  • 5Kong DL, Chen CZ, Yu YT, et al. Clinical trials of type I and type II imrnunoadsorbents for systemic lupus erythrematosus therapy. Artif Organs, 1998, 22: 644-650.
  • 6任新生.血液净化治疗与危重病[J].中华急诊医学杂志,2003,12(2):77-78. 被引量:32
  • 7杨丽,程焱.乙酰胆碱受体α亚单位125~147段多肽致实验性自身免疫性重症肌无力[J].中华神经科杂志,2003,36(1):32-34. 被引量:6

共引文献6

同被引文献10

  • 1杨丽,程焱.全血灌流吸附治疗重症肌无力的实验研究[J].中华急诊医学杂志,2004,13(10):670-672. 被引量:7
  • 2张旭,许贤豪.牛坐骨神经髓鞘碱性蛋白提取及初步应用[J].温州医学院学报,1993,23(4):215-218. 被引量:1
  • 3周文斌,周颖,肖波.趋化因子在实验性自身免疫性神经炎中的动态表达[J].中国神经免疫学和神经病学杂志,2005,12(5):262-264. 被引量:2
  • 4刘学东,贾宏阁,唐小凤,王波,吴中亮.双重血浆置换与常规疗法治疗急性吉兰-巴雷综合征的随机对照研究[J].中国神经免疫学和神经病学杂志,2007,14(2):83-86. 被引量:5
  • 5van Doorn PA,Ruts L,Jacobs BC.Clinical features,pathogenesis,and treatment of Guillain-Barré syndrome[J].Lancet Neurol,2008,7(10):939-950.
  • 6McGrogan A,Madle GC,Seaman HE,et al.The epidemiology of Guillain-Barré syndrome worldwide.A systematic literature review[J].Neuroepidemiology.2009,32(2):150-163.
  • 7Yang L,Cheng Y,Yan WR,et al.Extracorporeal whole blood immunoadsorption of autoimmune myasthenia gravis by cellulose tryptophan[J].Artif Cells Blood Substit Immobil Biotechnol,2004,32(4),529-528.
  • 8Gabriel CM,Gregson NA,Redford EJ,et al.Human immunoglobulin ameliorates rat experimental autoimmune neuritis[J].Brain,1997,120:1533-1540.
  • 9Matsumoto T,Ono Y,Kurono M,et al.Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux[J].J Pharmacol Sci,2009,109(2):203-210.
  • 10Okamiya S,Ogino M,Ogino Y,et al.Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome[J].Ther Apher Dial,2004,8(3):248-253.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部